Novel Approaches to Vaccine Development
Existing stage advancements are keys to the achievement rate required when growing quick track projects to assess antibodies or immunotherapy approaches. Therion Biologics has built up an arrangement of pox infection vectors that have a setup wellbeing profile in people and can at the same time express numerous antigens, co-stimulatory atoms, and safe regulating proteins. These vectors have demonstrated security and mediocrity and are productive in assembling forms. Alpha Vax built up an exceptional framework to create "replicon&particles" making safe promising immunizations against alphaviruses (e.g., Venezuelan Equine Encephalitis).
- Track 1-1 Existing TB Vaccine-BCG
- Track 2-2 Therapeutic Vaccine
- Track 3-3 Novel mycobacterial vectors
- Track 4-4 Heterologous prime-boost strategies
- Track 5-5 Future Challenges